Angiogenesis inhibitors for advanced hepatocellular carcinoma: in search for the right partner

被引：1
|
作者：
Campani, Claudia [1 ]
Rimassa, Lorenza [2 ,3 ]
Personeni, Nicola [2 ,3 ]
Marra, Fabio [1 ]
机构：
[1] Univ Florence, Dept Expt & Clin Med, Internal Med & Hepatol Unit, Florence, Italy
[2] Humanitas Clin & Res Ctr IRCCS, Humanitas Canc Ctr, Med Oncol & Hematol Unit, Milan, Italy
[3] Humanitas Univ, Dept Biomed Sci, Milan, Italy
来源：
ANNALS OF TRANSLATIONAL MEDICINE | 2020年 / 8卷 / 22期
关键词：
RECEPTOR-LIKE KINASE-1; PHASE-III; DOUBLE-BLIND; LIGAND TRAP; SORAFENIB; DALANTERCEPT; THERAPY; CABOZANTINIB; COMBINATION; RECURRENT;
D O I：
10.21037/atm-20-3788
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：7
相关论文
共 50 条
  • [21] Transarterial Radioembolization for the Treatment of Advanced Hepatocellular Carcinoma Invading the Right Atrium
    Girardet, Raphael
    Boughdad, Sarah
    Digklia, Antonia
    Beigelman, Catherine
    Meyer, Marie
    Schaefer, Niklaus
    Vermersch, Mathilde
    Hocquelet, Arnaud
    Tsoumakidou, Georgia
    Denys, Alban
    Duran, Rafael
    [J]. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2020, 43 (11) : 1712 - 1715
  • [22] Transarterial Radioembolization for the Treatment of Advanced Hepatocellular Carcinoma Invading the Right Atrium
    Raphaël Girardet
    Sarah Boughdad
    Antonia Digklia
    Catherine Beigelman
    Marie Meyer
    Niklaus Schaefer
    Mathilde Vermersch
    Arnaud Hocquelet
    Georgia Tsoumakidou
    Alban Denys
    Rafael Duran
    [J]. CardioVascular and Interventional Radiology, 2020, 43 : 1712 - 1715
  • [23] Immune Checkpoint Inhibitors for Advanced Hepatocellular Carcinoma: Monotherapies and Combined Therapies
    Ouyang, Tao
    Kan, Xuefeng
    Zheng, Chuansheng
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [24] Current progress of immune checkpoint inhibitors in the treatment of advanced hepatocellular carcinoma
    Yin, Xiaoqiang
    Wu, Tongchui
    Lan, Yadong
    Yang, Wulin
    [J]. BIOSCIENCE REPORTS, 2022, 42 (02)
  • [25] Combining telomerase inhibitors with sorafenib as a treatment strategy in advanced hepatocellular carcinoma
    Uldry, E.
    Faes, S.
    Santoro, T.
    Planche, A.
    Demartines, N.
    Dormond, O.
    [J]. BRITISH JOURNAL OF SURGERY, 2016, 103 : 22 - 22
  • [26] Lenvatinib With or Without Immune Checkpoint Inhibitors in Subsets of Advanced Hepatocellular Carcinoma
    Teng, Yu-xian
    Guo, Ping-Ping
    Qin, Ke-Zhang
    Chen, Kang
    Papatheodoridis, George
    Xiang, Bang-De
    Mia, Liang
    Zhong, Jian-Hong
    [J]. EURASIAN JOURNAL OF MEDICINE AND ONCOLOGY, 2022, 6 (01): : 25 - 29
  • [27] Enlighting the Shadow for Advanced Hepatocellular Carcinoma: Immunotherapy with Immune Checkpoint Inhibitors
    Sahin B.
    [J]. Journal of Gastrointestinal Cancer, 2017, 48 (3) : 288 - 290
  • [28] Features of microvessel density (MVD) and angiogenesis inhibitors in therapeutic approach of hepatocellular carcinoma (HCC)
    Berretta, M.
    Cobellis, G.
    Franco, R.
    Panarese, I.
    Rinaldi, B.
    Nasti, G.
    Di Francia, R.
    Rinaldi, L.
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (22) : 10139 - 10150
  • [29] Role of angiogenesis in hepatitis and hepatocellular carcinoma
    Ker, CG
    Chen, HY
    Juan, CC
    Lo, HW
    Shen, YY
    Chen, JS
    Lee, KT
    Sheen, PC
    [J]. HEPATO-GASTROENTEROLOGY, 1999, 46 (26) : 646 - 650
  • [30] Effects of tetrahydrobiopterin on the angiogenesis in hepatocellular carcinoma
    代佑果
    [J]. China Medical Abstracts (Internal Medicine), 2017, 34 (01) : 45 - 46
12345